Specific music therapy techniques in the treatment of primary headache disorders in adolescents: a randomized attention-placebo-controlled trial
Koenig J, Oelkers-Ax R, Kaess M, Parzer P, Lenzen C, Hillecke TK, Resch F
The journal of pain · 13 citas
Cómo se estudió
- Diseño
- Ensayo controlado aleatorizado (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación independiente
- Universidad u hospital
- Universität Heidelberg
Según 1 financiador declarado.
Publicación
- Publicado
- 2013-07-19 · J Pain · vol. 14 · número 10 · págs. 1196–1207
- Editorial
- Elsevier BV
- Citado
- 39 citas · más que el 83% de estudios similares · 1.7× el promedio de su campo
- Referencias
- 68 trabajos
- Acceso
- Lectura gratuita
- Áreas de investigación
- Migraine and Headache Studies · Music Therapy and Health · Temporomandibular Joint Disorders
- Palabras clave
- music therapy, primary headache, migraine, tension-type headache, adolescents, headache frequency, headache severity, non-pharmacological treatment, treatment efficacy
- MeSH
- humans, treatment outcome, music therapy, medical records, follow-up studies, prospective studies, affective symptoms, patient compliance, attention, mental disorders, child behavior disorders, neuropsychological tests, adolescent, child, female, male, headache disorders, primary, relaxation therapy
7 autores
- Julian Koenig🇩🇪 · autor de correspondenciaSRH University of Applied Sciences Heidelberg
- Rieke Oelkers‐Ax🇩🇪Heidelberg University
- Michael Kaess🇩🇪Heidelberg University
- Peter Parzer🇩🇪Heidelberg University
- Christoph Lenzen🇩🇪Heidelberg University
- Thomas Karl Hillecke🇩🇪SRH University of Applied Sciences Heidelberg
- Franz Resch🇩🇪Heidelberg University
Resumen
El texto original del estudio, en el idioma en que se publicó.
Unlabelled
Migraine and tension-type headache have a high prevalence in children and adolescents. In addition to common pharmacologic and nonpharmacologic interventions, music therapy has been shown to be efficient in the prophylaxis of pediatric migraine. This study aimed to assess the efficacy of specific music therapy techniques in the treatment of adolescents with primary headache (tension-type headache and migraine). A prospective, randomized, attention-placebo-controlled parallel group trial was conducted. Following an 8-week baseline, patients were randomized to either music therapy (n = 40) or a rhythm pedagogic program (n = 38) designed as an "attention placebo" over 6 sessions within 8 weeks. Reduction of both headache frequency and intensity after treatment (8-week postline) as well as 6 months after treatment were taken as the efficacy variables. Treatments were delivered in equal dose and frequency by the same group of therapists. Data analysis of subjects completing the protocol showed that neither treatment was superior to the other at any point of measurement (posttreatment and follow-up). Intention-to-treat analysis revealed no impact of drop-out on these results. Both groups showed a moderate mean reduction of headache frequency posttreatment of about 20%, but only small numbers of responders (50% frequency reduction). Follow-up data showed no significant deteriorations or improvements.
Perspective
This article presents a randomized placebo-controlled trial on music therapy in the treatment of adolescents with frequent primary headache. Music therapy is not superior to an attention placebo within this study. These results draw attention to the need of providing adequate controls within therapeutic trials in the treatment of pain.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.